LOGO 2120 (Valproic acid 250 mg)

Pill imprint LOGO 2120 has been identified as Valproic acid 250 mg.

Valproic acid is used in the treatment of bipolar disorder; epilepsy; schizoaffective disorder; migraine prevention; seizures (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Valproic acid 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Valproic acid

Imprint:

LOGO 2120

Strength:

250 mg

Color:

White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Manufacturer:

United Research Laboratories/Mutual Pharmaceutical Company

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.